Duopharma Seeking To Diversify Manufacturing Domain
from The Breakfast Grille Hosted by BFM Media
Malaysian pharmaceutical Duopharma Biotech achieved their best financial performance to date in 2022, reaching record highs for revenue and profit. However 2023 was not as kind, with profit after tax falling by 25% despite top line growth. How are they looking to reverse course in 2024? We discuss strategy with Group Managing Director Leonard Ariff Abdul Shatar.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of The Breakfast Grille?
This episode is 26 minutes long.
When was this The Breakfast Grille episode published?
This episode was published on March 12, 2024.
Can I download this The Breakfast Grille episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.